Inicio › Trastorno depresivo mayor › Florida
Ensayos clínicos de Trastorno depresivo mayor en Florida
33 estudios sobre Trastorno depresivo mayor buscan participantes en Florida.
Ciudades en Florida
- Orlando18 estudios
- Miami17 estudios
- Tampa17 estudios
- Jacksonville12 estudios
- Hollywood7 estudios
- West Palm Beach6 estudios
- Hialeah6 estudios
- Brandon5 estudios
- Palm Bay4 estudios
- Miami Gardens4 estudios
- Naples4 estudios
- Cape Coral3 estudios
- Deltona3 estudios
Texto oficial del estudio (inglés)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- CNS Healthcare, Jacksonville
- Accel Research Sites - Maitland, Maitland
- Aqualane Clinical Research, Naples
- y 1 más
ReclutandoFase 3
Edades de 18 a 85 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Jacksonville
- Seaport Investigator Site, Lauderhill
- Seaport Investigator Site, Orlando
- y 2 más
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 10 nov 2026 · NCT07065240A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Clinical Neuroscience Solutions, LLC (Jacksonville), Jacksonville
- K2 Medical Research (Maitland), Maitland
- Clinical Neuroscience Solutions, LLC (Orlando), Orlando
- y 1 más
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 9 nov 2026 · NCT07592689Neuromodulation of Motivation and Reward Oscillations
- The BRAINS Lab at Florida State University, Tallahassee
- The Riddle Lab at Florida State University, Tallahassee
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 55 · Todos los sexos · Actualizado el 9 nov 2026 · NCT07924852Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
- AdventHealth Neuroscience Institute, Orlando
Reclutando
Edades de 60 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT05877885ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- New Access Research and Medical Services, Inc., Fort Myers
- The Medici Medical Research, Hollywood
- Clinical Neuroscience Solutions, Inc., Orlando
- y 2 más
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07284667A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Encore Medical Research, Hollywood
- K2 Medical Research - Maitland, Maitland
- Life Medical Research Group Corp, Miami Gardens
- y 5 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07412756Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Clinical Research of Brandon, Brandon
- Nuovida Research Center, Miami
- Psych Me Medical Research Inc, Tampa
- y 2 más
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 3 nov 2026 · NCT06559306A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- JEM Research Institute, Atlantis
- Bradenton Research Center, Inc., Bradenton
- Key Clinical Research, Bradenton
- y 6 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07775300Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Premier Clinical Research Institute, Miami
- Miami Jewish Health System, Miami
- Interventional Psychiatry of Tampa Bay, Tampa
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 3 nov 2026 · NCT05850689A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- UHC Research, Doral
- Reliable Clinical Research, Hialeah
- K2 Medical Research, Maitland
- y 4 más
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07573176Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Hollywood
- Neurocrine Clinical Site, Maitland
- Neurocrine Clinical Site, Maitland
- y 6 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06966401A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Clinical Research Site, Jacksonville
- Clinical Research Site, Maitland
- Clinical Research Site, Miami
- y 3 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07621237A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder
- Alkermes Investigator Site, Jacksonville
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07901179Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- CNS Healthcare - Jacksonville, Jacksonville
- Avantis Clinical Research, Miami
- CNS Healthcare of Orlando, Orlando
- y 3 más
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07226661Study of ALTO-300 in MDD
- Site 221, Tampa
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 26 oct 2026 · NCT05922878Neural Mechanisms of Real-world Emotions and Internalizing
- University of Miami, Coral Gables
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 35 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07891624A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Miami Gardens
- Neurocrine Clinical Site, Orlando
- Neurocrine Clinical Site, Palm Bay
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT07196501Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- USF Health, Tampa
Reclutando
Edades de 22 a 70 · Todos los sexos · Actualizado el 16 oct 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Hialeah
- Draig Clinical Site, Orlando
- Draig Clinical Site, Orlando
- y 2 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 14 oct 2026 · NCT07610473Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Jacksonville
- Clinical Research Site, Miami
- Clinical Research Site, Miami
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 13 oct 2026 · NCT07484217A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Miami
- Draig Clinical Site, Orlando
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 oct 2026 · NCT07300969Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Fort Myers
- Vanda Investigational Site, Miami
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bonita Springs
- Neurocrine Clinical Site, Hialeah
- Neurocrine Clinical Site, Miami
- y 3 más
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT07105111Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression
- Florida State University, Tallahassee
Reclutando
Edades de 18 a 65 · Todos los sexos · Actualizado el 31 ago 2026 · NCT06132581NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Hollywood
- Neurocrine Clinical Site, Tampa
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT06911112NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Maitland
- Neurocrine Clinical Site, Miami
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 ago 2026 · NCT06963021Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Clinical Neuroscience Solutions, Inc., Jacksonville
- D&H Pompano Research Center, LLC, Margate
- Premier Clinical Research Institute, Inc., Miami
- y 2 más
ReclutandoFase 2
Edades de 18 a 64 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Clinical Neuroscience Solutions, Inc, Jacksonville
- Premier Clinical Research Institute Inc, Miami
- Aqualane Clinical Research, Naples
- y 2 más
ReclutandoFase 2
Edades de 18 a 64 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07115329A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- CenExel Hollywood FL /ID# 278200, Hollywood
- Cns Healthcare - Jacksonville /ID# 277658, Jacksonville
- GMI Florida - Central Miami Medical Institute /ID# 278218, Miami
- y 2 más
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 15 jun 2026 · NCT07276997Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #108, Brandon
- Autobahn Site #110, Hialeah
- Autobahn Site #101, Jacksonville
- y 3 más
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 20 ene 2026 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Hollywood
- Neurocrine Clinical Site, Maitland
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2025 · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Brandon
- Clinical Research Site, Doral
- Clinical Research Site, Hialeah
- y 5 más
ReclutandoFase 4
Edades de 18 a 65 · Todos los sexos · Actualizado el 23 ene 2025 · NCT06223880De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.